What does ARCHI-MED do?

ARCHI-MED is an events organiser in Elsene. Private Limited, started on 17 July 2012, 1 establishment.

What is the address of ARCHI-MED?

The registered office of ARCHI-MED is located at Renbaanlaan 96 box 1, 1050 Elsene.

Is ARCHI-MED still active?

Yes. According to the CBE (30 October 2026) ARCHI-MED is active, legal situation “Normale toestand”, started on 17 July 2012.

Is ARCHI-MED registered on Peppol?

Yes, ARCHI-MED is registered on the Peppol network with ID 0208:0847461383.

What is the enterprise number of ARCHI-MED?

The enterprise number of ARCHI-MED is BE0847461383.

When was ARCHI-MED founded?

ARCHI-MED was founded on 17 July 2012.

Who are the directors of ARCHI-MED?

According to the 2025 annual accounts, the directors of ARCHI-MED are: Jérémie EVRARD, Yaroslav IKRAMOV.

Is ARCHI-MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 July 2012; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did ARCHI-MED make in 2025?

ARCHI-MED recorded a loss after taxes of € 641 in financial year 2025.

What is the revenue of ARCHI-MED?

As a small company, ARCHI-MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -66.

ARCHI-MED (Private Limited) - Elsene - BE0847461383

Dossier ARCHI-MED, printed on 30 October 2026 from databakkes.be/en/0847461383/archi-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 23 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

ARCHI-MED from Elsene, company number BE0847461383, closed financial year 2025 with a result of € -641 after tax. For that financial year ARCHI-MED recorded a gross margin of € -66 and equity of € -3,667. Compared with financial year 2024, the result moved from € -599 to € -641. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on May 28, 2026.

What it is worth Caution

€ -3,667

▼ € 641 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -641

▼ 7 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 359

▼ 17% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -34,367.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,000

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -856 Gross margin 2022: € -856 First fiscal year in the series	€ -64 Gross margin 2023: € -64 ▲ € 792 vs 2022 (€ -856) Favourable step	€ -64 Gross margin 2024: € -64 Unchanged (€ -64) Unfavourable step	€ -66 Gross margin 2025: € -66 ▼ € 2 vs 2024 (€ -64) Unfavourable step	▼ € 2
Profit after taxes	€ -1,698 Profit after taxes 2022: € -1,698 First fiscal year in the series	€ -569 Profit after taxes 2023: € -569 ▲ € 1,130 vs 2022 (€ -1,698) Favourable step	€ -599 Profit after taxes 2024: € -599 ▼ € 31 vs 2023 (€ -569) Unfavourable step	€ -641 Profit after taxes 2025: € -641 ▼ € 42 vs 2024 (€ -599) Unfavourable step	▼ € 42
Equity	€ -1,858 Equity 2022: € -1,858 First fiscal year in the series	€ -2,427 Equity 2023: € -2,427 ▼ € 569 vs 2022 (€ -1,858) Unfavourable step	€ -3,026 Equity 2024: € -3,026 ▼ € 599 vs 2023 (€ -2,427) Unfavourable step	€ -3,667 Equity 2025: € -3,667 ▼ € 641 vs 2024 (€ -3,026) Unfavourable step	▼ € 641
Total debts	€ 2,517 Total debts 2022: € 2,517 First fiscal year in the series	€ 3,248 Total debts 2023: € 3,248 ▲ 29% vs 2022 (€ 2,517) Unfavourable step	€ 4,211 Total debts 2024: € 4,211 ▲ 30% vs 2023 (€ 3,248) Unfavourable step	€ 4,777 Total debts 2025: € 4,777 ▲ 13% vs 2024 (€ 4,211) Unfavourable step	▲ 13%
Cash	€ 76 Cash 2022: € 76 First fiscal year in the series	€ 70 Cash 2023: € 70 ▼ 7% vs 2022 (€ 76) Unfavourable step	€ 435 Cash 2024: € 435 ▲ € 364 vs 2023 (€ 70) Favourable step	€ 359 Cash 2025: € 359 ▼ 17% vs 2024 (€ 435) Unfavourable step	▼ 17%
Retained profit	€ -32,558 Retained profit 2022: € -32,558 First fiscal year in the series	€ -33,127 Retained profit 2023: € -33,127 ▼ € 569 vs 2022 (€ -32,558) Unfavourable step	€ -33,726 Retained profit 2024: € -33,726 ▼ € 599 vs 2023 (€ -33,127) Unfavourable step	€ -34,367 Retained profit 2025: € -34,367 ▼ € 641 vs 2024 (€ -33,726) Unfavourable step	▼ € 641
Balance sheet total	€ 659 Balance sheet total 2022: € 659 First fiscal year in the series	€ 821 Balance sheet total 2023: € 821 ▲ 25% vs 2022 (€ 659) Unchanged	€ 1,185 Balance sheet total 2024: € 1,185 ▲ 44% vs 2023 (€ 821) Unchanged	€ 1,110 Balance sheet total 2025: € 1,110 ▼ 6% vs 2024 (€ 1,185) Unchanged	▼ 6%

Key figures of ARCHI-MED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ARCHI-MED?

What happened at ARCHI-MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 28, 2026 New annual accounts for financial year 2025: loss of € 641. Source: NBB ↗
2017 Jérémie EVRARD became a director. NBB
2017 Yaroslav IKRAMOV became a director. NBB
Jul 17, 2012 New establishment in Sint-Lambrechts-Woluwe. KBO
Jul 17, 2012 Start of the company according to the CBE. KBO

In short

From € 1,698 loss in 2022 to € 641 loss in 2025.

Original PDFs at the National Bank ↗

Management

KNOWLEDGE FUSION 100%

The stake of KNOWLEDGE FUSION comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

ARCHI-MED

Behind ARCHI-MED are Jérémie EVRARD and Yaroslav IKRAMOV. The shares are held by KNOWLEDGE FUSION (100%).

Directors

According to the 2025 annual accounts

Jérémie EVRARD

Manager

since 2017

Yaroslav IKRAMOV

Manager

Also active at: HARDWHERE

since 2017

Shareholders

KNOWLEDGE FUSION

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Renbaanlaan 96 box 1

1050 Elsene

2.212.709.164

Almaplein 3

1200 Sint-Lambrechts-Woluwe

Active since 17 July 2012

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

HARDWHERE same network

€ 184,441 gross margin · 2025

Association des Copropriétaires Jardins de la Cambre, sise à Ixelles, av de l'Hippodrome 96 et Rue des Echevins 72

THIERRY Hélène - DE LANGLE Alexis

EURO-MEDITERANNEAN SYBERGIES FORUM

BRAINCRAFT

€ 216,478 gross margin · 2025

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0847.461.383
VAT number: BE 0847.461.383
Registered office: Renbaanlaan 96 bus 1, 1050 Elsene
Names & denominations: ARCHI-MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 July 2012
Peppol: Active · Active since 11 Dec 2025
Activities · NACE: Organisatie van congressen en beurzen

View on CBE Public ↗ Annual accounts (NBB) ↗